Recommended Free Tools
QIAGEN completed its acquisition of Seattle-based Parse Biosciences on December 2, 2025. The roughly $225 million figure in the original announcement was the upfront cash payment, not the full set of reported acquisition-accounting figures: QIAGEN later reported $231.0 million in cash consideration, plus potential milestone payments of up to $55 million.
When did QIAGEN acquire Parse Biosciences?
QIAGEN announced a definitive agreement to acquire Parse on November 4, 2025, and at that time expected the transaction to close in December, subject to U.S. antitrust clearance and customary conditions. QIAGEN’s second-quarter 2026 report later confirmed that it acquired 100% of Parse’s shares on December 2, 2025. The November announcement date and the December closing date refer to different stages of the transaction. QIAGEN’s November 4, 2025 announcement; QIAGEN’s second-quarter 2026 filing.
How much did QIAGEN pay?
The deal’s headline amount and the later accounting figures describe different parts of the transaction, reported at different times. QIAGEN’s acquisition announcement described approximately $225 million in upfront cash and up to $55 million in additional milestone payments for Parse equityholders over multiple years. In its 2026 second-quarter filing, QIAGEN reported $231.0 million in cash consideration, including $33.0 million retained in escrow for working-capital adjustments and possible claims.
| Figure | What it describes | Source and timing |
|---|---|---|
| Approximately $225 million | Announced upfront cash payment | QIAGEN announcement, November 4, 2025 |
| $231.0 million | Cash consideration reported in acquisition accounting; $33.0 million was retained in escrow for working-capital adjustments and possible claims | QIAGEN second-quarter 2026 filing |
| Up to $55 million | Maximum potential contingent milestone payments | QIAGEN announcement, November 4, 2025 |
| $13.4 million | Acquisition-date fair value recorded for the contingent payments, compared with the $55.0 million maximum | QIAGEN second-quarter 2026 filing |
The $13.4 million fair value is an accounting estimate of contingent consideration at the acquisition date; it is not the maximum amount Parse equityholders could receive. QIAGEN said its purchase-price allocation was still preliminary as of June 30, 2026 and could change.
#1 Best Overall
- REVIEW IMPORTANT TEST INFO AND ELIGIBILITY: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk*, Carrier Status*, and Pharmacogenetics** reports at 23andme. org/test-info and 23andme. org/test-info/pharmacogenetics. To be eligible for Total Health, you must be 18 years or older and live in the US — excluding AL, GA, HI, LA, MS, NJ, NY, PR, RI, SC, TN, and US territories (due to state and regional restrictions). You must not have received a blood transfusion in the last 30 days or a bone marrow transplant.
- ACCESS CLINICAL-GRADE EXOME SEQUENCING: Go beyond standard DNA genotyping. Clinical-grade Exome Sequencing analyzes analyzes a portion of your total DNA, detecting 200x more disease-causing variants than genotyping.Δ Valid payment method required at kit registration.
- TRACK 55+ BIOMARKERS TWICE A YEAR: Track your health progression with twice-yearly lab blood testing. Evaluate 55+ cardiometabolic biomarkers, calculate your Biological Age, and discover how your DNA could influence weight loss and nausea on GLP-1 medications.
- REVIEW RESULTS WITH A GENETICS-TRAINED CLINICIAN: Meet virtually with clinicians trained in genetics-informed care, message your care team with questions, and get a personalized preventive care plan to discuss next steps.
- INCLUDES EVERYTHING IN PREMIUM ANCESTRY + HEALTH: Get DNA insights on Condition*, Carrier Status*, Pharmacogenetics how your body processes certain medications**), and Wellness. Access preventive health features like Health Tracks(SM) and advanced ancestry features like Historical Matches(R), Reconstructed Ancestors, and up to 5,000 DNA Relatives.
What does Parse Biosciences do?
Founded in Seattle in 2018, Parse develops tools for single-cell research—methods that measure gene activity in individual cells rather than averaging signals across a mixed sample. Its Evercode platform uses chemistry-based, instrument-free workflows for high-throughput single-cell RNA analysis. The company also offers Trailmaker, cloud-based analysis software, and GigaLab, a processing service for large-scale projects. These product descriptions are from QIAGEN’s announcement and filing.
QIAGEN said Parse technologies were used in more than 3,000 labs across more than 40 countries. Its 2025 announcement also cited GigaLab capacity of 2.5 billion cells per year and the Tahoe-100M dataset, which contains more than 100 million single-cell transcriptomes. These are company-reported figures, not independent assessments of product performance or market adoption.
Rank #2
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
Why did QIAGEN buy Parse?
QIAGEN said the acquisition would extend its Sample technologies portfolio into scalable single-cell research and could complement QIAGEN Digital Insights, its bioinformatics business. Its stated strategy was to combine Parse’s chemistry with QIAGEN sample technologies and data-analysis capabilities to support large biological datasets and AI-driven drug discovery. Those are the company’s goals for the deal, not outcomes established by the acquisition itself.
QIAGEN also pointed to a broader market opportunity. Its announcement estimated the global single-cell market at approximately $1.2 billion in 2024, growing to $2.1 billion by 2029 at about 10% annually. That is a company-cited market estimate, not an independently verified market measurement.
Rank #3
- REVIEW IMPORTANT TEST INFO: There is a lot to consider with genetic testing. Before purchasing, review important information about Genetic Health Risk*, Carrier Status*, and Pharmacogenetics** reports at 23andme. org/test-info and 23andme. org/test-info/pharmacogenetics. A portion of your purchase may be eligible for FSA/HSA reimbursement***.
- UNDERSTAND YOUR GENETIC HEALTH: Receive 160+ personalized genetic reports, including 50+ Conditions* and wellness reports. Get insights into heart health, metabolic health, mental health, and more. You choose whether to view certain reports.
- TRACK HEALTH GOALS: Health Tracks(SM) show how everyday choices may shape your health over time. Opt in to the Family Health History Tree to input and track information to share with your healthcare provider.
- PLAN AHEAD WITH 45+ CARRIER STATUS REPORTS*: Find out whether you carry a genetic variant for inherited conditions across categories like blood, lung, and hearing health, information you can bring to family planning conversations with your healthcare provider.
- LEARN HOW YOUR BODY MAY RESPOND: FDA-authorized pharmacogenetics reports show how your DNA may impact the way your body processes certain medications**, including some used in heart health and mental health care. Talk to your healthcare provider before making any medication changes.
What did QIAGEN forecast for Parse sales?
When it announced the agreement in November 2025, QIAGEN forecast that Parse would contribute approximately $40 million in sales in 2026, equivalent to about two percentage points of growth, and projected strong double-digit growth in subsequent years. QIAGEN repeated the approximate $40 million expectation in its 2026 priorities release. These are forecasts, not confirmed sales results. In its second-quarter 2026 filing, QIAGEN said Parse’s revenue and earnings since acquisition had not been significant to consolidated results. November 2025 announcement; 2026 priorities release; second-quarter 2026 filing.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What was said about Parse’s operations after the deal?
In its November 4, 2025 customer announcement, Parse said it planned to continue as a QIAGEN subsidiary, keep full operations in its Seattle headquarters and other locations, retain customer contacts, and maintain access to Evercode products and Trailmaker without interruption. That statement describes the company’s plan at announcement; it does not independently establish the current experience of customers or employees. Parse’s November 4, 2025 customer announcement.
Quick Recap
Best Value
- DISCOVER WHAT MAKES YOUR BODY UNIQUE - Stop guessing how your body processes nutrients, produces energy, and manages everyday stress. This DNA testing kit analyzes 13 methylation genes to uncover the specific variations that may be affecting your energy, nutrient absorption, and stress response; backed by 500+ peer-reviewed studies.
- 13 METHYLATION GENES ANALYZED - Most methylation test options check just MTHFR or a handful of variants. This panel covers MTHFR, COMT, MTR & MTRR, and 10 more critical genes, a more comprehensive picture of how your body processes B-vitamins, supports detox pathways, and regulates mood-related functions.
- ACTIONABLE REPORTS, NOT RAW DATA - Go far beyond simple genetic reporting. This genetic testing kit delivers clear reports that translate complex methylation-genotype data about methylation into personalized insights and suggestions, so you know exactly what to explore next about your nutrition, energy, supplementation, and daily habits. Complimentary call with an expert included.
- SIMPLE CHEEK SWAB, FAST RESULTS - No blood draws or doctor visits. Swab, seal, and mail it back in minutes. Receive your results in 3-5 weeks, not the 2-3 months other DNA tests can take. Everything you need is in the box
- YOUR DNA DATA STAYS PRIVATE - Your genetic data is yours. Period. It is never sold to third parties, never shared with insurance companies, never accessed without your permission. You keep 100% ownership with full control, including the right to delete it anytime. Trusted by tens of thousands. This product is an informational wellness tool, not a substitute for professional healthcare guidance.
Rank #4
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600 places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA provides more precise ancestral origins with greater geographic detail. Our innovative SideView technology takes your results even further by showing your origins and matches by parental side. *Some DNA features require an Ancestry subscription.
- BUILD YOUR FAMILY TREE: Combine what you learn from your DNA results with an Ancestry subscription and gain access to millions of family trees and the world's largest collection of online family history records. *Access to record collections varies depending on subscription level.
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
